Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label on the page was updated from v3.6.0 to v3.6.2, indicating an update to the page’s underlying software version.
    Difference
    0.0%
    Check dated 2026-06-29T08:41:13.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added navigation/help sections to the Study Details page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). Standardized the Intervention/Treatment label formatting (Intervention/Treatment instead of Intervention / Treatment) and updated the page revision from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T05:46:07.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    An additional recruitment site in Chicago, Illinois (Investigational Site 0024) has been added. This update increases the total number of locations from 16 to 17.
    Difference
    0.4%
    Check dated 2026-06-08T03:44:17.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study's listed locations were updated from 17 to 16, with the Cincinnati, Ohio site removed from the recruitment roster. The overall location count now reflects 16 participating sites.
    Difference
    0.4%
    Check dated 2026-05-24T14:00:32.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small internal update. This update does not appear to alter the study information or other user-facing content.
    Difference
    0.0%
    Check dated 2026-05-17T09:11:21.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Amendment 13 closed enrollment for rrCHL, MSI-H solid tumors, TMB-H solid tumors, and 12 to <18 years old with advanced melanoma, and Amendment 8 closed enrollment for solid tumors and melanoma in 6 months to <12 years old. These changes narrow participant eligibility and reflect updates to the study plan.
    Difference
    0.9%
    Check dated 2026-05-10T08:34:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.